Oncoprotein Bcl-2 and microsatellite instability are associated with disease-free survival and treatment response in colorectal cancer.
Bendardaf R. et al, (2008), Oncol Rep, 20, 999 - 1004
Thymidylate synthase and microsatellite instability in colorectal cancer: implications for disease free survival, treatment response and survival with metastases.
Bendardaf R. et al, (2008), Acta Oncol, 47, 1046 - 1053
Thymidylate synthase expression in primary colorectal tumours is correlated with its expression in metastases.
Bendardaf R. et al, (2007), Scand J Gastroenterol, 42, 471 - 476
Mismatch repair status is a predictive factor of tumour response to 5-fluorouracil and irinotecan chemotherapy in patients with advanced colorectal cancer.
Bendardaf R. et al, (2007), Tumour Biol, 28, 212 - 220
Comparison of CD44 expression in primary tumours and metastases of colorectal cancer.
Bendardaf R. et al, (2006), Oncol Rep, 16, 741 - 746
E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome.
Elzagheid A. et al, (2006), World J Gastroenterol, 12, 4304 - 4309
Thymidylate synthase expression levels: a prognostic and predictive role in advanced colorectal cancer.
Bendardaf R. et al, (2005), Oncol Rep, 14, 657 - 662
Nuclear area is a prognostic determinant in advanced colorectal cancer.
Buhmeida A. et al, (2005), Anticancer Res, 25, 3083 - 3088
E-cadherin, CD44s and CD44v6 correlate with tumour differentiation in colorectal cancer.
Bendardaf R. et al, (2005), Oncol Rep, 13, 831 - 835
Prognostic and predictive molecular markers in colorectal carcinoma.
Bendardaf R. et al, (2004), Anticancer Res, 24, 2519 - 2530
CD44 variant 6 expression predicts response to treatment in advanced colorectal cancer.
Bendardaf R. et al, (2004), Oncol Rep, 11, 41 - 45
Response to chemotherapy (irinotecan plus 5-fluorouracil) in colorectal carcinoma can be predicted by tumour DNA content.
Bendardaf R. et al, (2004), Oncology, 66, 46 - 52
Refining the relation between 'first hits' and 'second hits' at the APC locus: the 'loose fit' model and evidence for differences in somatic mutation spectra among patients.
Crabtree M. et al, (2003), Oncogene, 22, 4257 - 4265
Apoptotic index and bcl-2 expression as prognostic factors in colorectal carcinoma.
Bendardaf R. et al, (2003), Oncology, 64, 435 - 442
Low collagenase-1 (MMP-1) and MT1-MMP expression levels are favourable survival markers in advanced colorectal carcinoma.
Bendardaf R. et al, (2003), Oncology, 65, 337 - 346
Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APC.
Sieber OM. et al, (2002), Proc Natl Acad Sci U S A, 99, 16910 - 16915
Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis.
Groves C. et al, (2002), Am J Pathol, 160, 2055 - 2061
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer.
Tomlinson IPM. et al, (2002), Nat Genet, 30, 406 - 410
Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomas.
Sieber OM. et al, (2002), Proc Natl Acad Sci U S A, 99, 2954 - 2958
Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomas
Sieber OM. et al, (2002), PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 99, 2954 - 2958